← SynDRA
NITAZOXANIDE
SynDRA canonical compound SYN0006091 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | pyruvate ferredoxin oxidoreductase inhibitor |
|---|
| Indication | diarrhea |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- AKR1B1
- ANO1
- Crypto CpPNO
- PFOR
- STAT3
Mechanisms of action (all sources)
- pyruvate ferredoxin oxidoreductase inhibitor
- Crypto CpPNO MODULATOR
- PFOR INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR3A
- BDKRB2
- HRH3
- CHRM1
- CHRM2
- SLC6A3
- CHRNA4
- SLC6A2
- SLC29A1
- DRD1
- DRD2
- NR1I2
- OPRD1
- ESR1
- PTGS1
- HTR2C
- HDAC6
- CCKAR
- CCKBR
- SLC6A4
- ADORA3
- TBXA2R
- MAOA
- ADORA1
- AGTR1
- ADRB2
- ADRB1
- ADRA2B
- ADORA2A
- ADRA1A
- PDE4A
- PDE3A
- OPRM1
- NR3C1
- OPRK1
- NFE2L2
- NR1H4
- NPC1
- NPSR1
- NPY1R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- NTMT1
- KCNQ1
- KSYK
- LRC26
- MCLN3
- NF2L2
- NTM1A
- OXYR
- ATAD5
- PADI4
- RARA
- RXFP1
- S12A5
- SC6A3
- SMN
- KCMB2
- KCMA1
- IFNB1
- HSPB1
- HLAB
- HDAC9
- HCRTR1
- GLI3
- ESRRA
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP1A2
- CP19A
- ATXN2
- SYK
Drug classes
- Antiprotozoal
- Anti-Infective Agents
- Antiparasitic Agents
ATC classes
- P01A · AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
Cross-references
Synonyms
- ALINIA
- Alinia
- nitazode
- nitazoxanida
- nizonide
- Nitazoxanida
- NSC-697855
- NSC-760057
- PH-5776
- Colufase
- Cryptaz
- Daxon
- Heliton
- Nitazoxanid
- Nitazoxanidum
- Taenitaz
- Tizoxanide glucuronide
- AZT + Nitazoxanide
- Alinia (TN)
- Annita (TN)
- Azt+ nitazoxanide
- Daxon (TN)
- Dexidex (TN)
- Kidonax (TN)
- Nitax (TN)
- Nitazox (TN)
- Nitazoxanida [INN-Spanish]
- Nitazoxanide [USAN:INN]
- Nitazoxanidum [INN-Latin]
- Pacovanton (TN)
- Paramix (TN)
- Phavic-1
- Zox (TN)
- Nitazoxanide (USAN/INN)
- Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
- Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-
- N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
Reported adverse events
- Gastrointestinal disorder
Look up NITAZOXANIDE in the interactive SynDRA portal →